Skip to main content
×
Home
Psychotic Depression
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 6
  • Cited by
    This book has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Shorter, Edward and Segesser, Kathryn 2013. Traditional Chinese Medicine and Western Psychopharmacology: Building Bridges. Phytotherapy Research, Vol. 27, Issue. 12, p. 1739.


    Altamura, A. Carlo Serati, Marta Albano, Alessandra Paoli, Riccardo A. Glick, Ira D. and Dell’Osso, Bernardo 2011. An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses. European Archives of Psychiatry and Clinical Neuroscience, Vol. 261, Issue. 7, p. 489.


    Herman, Sanford and Sadovsky, Richard 2010. Psychosocial health screening and recognizing early signs of psychosocial distress. Journal of Men's Health, Vol. 7, Issue. 1, p. 73.


    Lake, C. Ray 2010. The Validity of Schizophrenia vs. Bipolar Disorder. Psychiatric Annals, Vol. 40, Issue. 2, p. 77.


    Lake, C. Ray 2010. Why the Kraepelinian Dichotomy and Schizophrenia Have not Followed the Neuroses. Psychiatric Annals, Vol. 40, Issue. 3, p. 137.


    Swartz, Conrad M. 2010. Psychotic Depression or Schizophrenia. Psychiatric Annals, Vol. 40, Issue. 2, p. 92.


    ×
  • Export citation
  • Recommend to librarian
  • Recommend this book

    Email your librarian or administrator to recommend adding this book to your organisation's collection.

    Psychotic Depression
    • Online ISBN: 9780511547201
    • Book DOI: https://doi.org/10.1017/CBO9780511547201
    Please enter your name
    Please enter a valid email address
    Who would you like to send this to? *
    ×
  • Buy the print book

Book description

Psychotic depression is a distinct and acute clinical condition along the spectrum of depressive disorders. It can manifest itself in many ways and often induces very violent and suicidal behavior. This book aims to help clinical practitioners and trainees describe their observations of psychotic depression, formulate treatment, and express expectations of recovery from illness. It focuses on all facets of the disorder, from clinical history to coverage of diagnostic and treatment protocols. Medical readers of this book will come away able to diagnose and readily treat psychotic depression and thus will be able to serve their patients better. Non-physician readers will come away with the message that this is a terrible illness, but there is hope.

Reviews

Review of the hardback:'It has practical wisdom to offer, and the crafters of DSM-V could well give thought to some of its provocative concepts.'

Source: Psychiatric Services

    • Aa
    • Aa
Refine List
Actions for selected content:
Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Send to Kindle
  • Send to Dropbox
  • Send to Google Drive
  • Send content to

    To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to .

    To send content to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

    Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

    Find out more about the Kindle Personal Document Service.

    Please be advised that item(s) you selected are not available.
    You are about to send:
    ×

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
×

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.


D. Aarsland , J. P. Larsen , J. L. Cummings , and K. Laake 1999. Prevalence and clinical correlates of psychotic symptoms in Parkinson Disease. A community-based study. Arch Neurol 56: 595–601.

R. Abrams and M. A. Taylor 1983. The importance of mood-incongruent psychotic symptoms in melancholia. J Affect Disord 5: 179–81.

J. D. Amsterdam and J. Shults 2005. Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: A double-blind, placebo-substitution, continuation study. Int Clin Psychopharmacol 20: 257–64.

O. A. Andreassen , R. J. Ferrante , T. O. Aamo , et al. 2003. Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats. Neuroscience 122: 717–25.

F. Angst , H. H. Stassen , P. J. Clayton , and J. Angst 2002. Mortality of patients with mood disorders: Follow-up over 34–38 years. J Affect Disord 68: 167–81.

R. F. Anton Jr. and E. A. Burch Jr.1993. Response of psychotic depression subtypes to pharmacotherapy. J Affect Disord 28: 125–31.

T. A. Aronson , S. Shukla , A. Hoff , and B. Cook 1988. Proposed delusional depression subtypes: Preliminary evidence from a retrospective study of phenomenology and treatment course. J Affect Disord 14: 69–74

B. Arroll , S. Macgillivray , S. Ogston , et al. 2005. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: A meta-analysis. Ann Family Med 3: 449–56.

D. Avery and G. Winokur 1976. Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry 33: 1029–37.

J. K. Belanoff , A. J. Rothschild , F. Cassidy , et al. 2002. An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol Psychiatry 52: 386–92.

L. Bellini , F. Gatti , M. Gasperini , and E. Smeraldi 1992. A comparison between delusional and non-delusional depressives. J Affect Disord 25: 129–38.

T. K. Birkenhager , E. M. Pluijms , and S. A. Lucius 2003. ECT response in delusional versus non-delusional depressed inpatients. J Affect Disord 74: 191–5.

V. Bonomo and A. M. Fogliani 2000. Citalopram and haloperidol for psychotic depression. Am J Psychiatry 157: 1706–7.

M. B. Bowers and M. E. Swigar 1988. Psychotic patients who become worse on neuroleptics. J Clin Psychopharmacol 8: 417–21.

J. D. Bremner , M. Vythinlingam , C. K. Ng , et al. 2003. Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: Implications for the neural circuitry of depression. JAMA 289: 3125–34.

I. F. Brockington , A. Roper , J. Copas , et al. 1991. Schizophrenia, bipolar disorder and depression. A discriminant analysis, using “lifetime” psychopathology ratings. Br J Psychiatry 159: 485–94.

G. W. Brown , M. Ni Bhrolchain , and T. O. Harris 1979. Psychotic and neurotic depression. Part 3. Aetiological and background factors. J Affect Disord 1: 195–211.

R. P. Brown , A. Frances , J. H. Kocsis , and J. J. Mann 1982. Psychotic vs. nonpsychotic depression: Comparison of treatment response. J Nerv Ment Dis 170: 635–7

T. A. Brown , L. A. Campbell , C. L. Lehman , et al. 2001. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol 110: 585–99.

E. A. Burch and T. J. Goldschmidt 1983. Loxapine in the treatment of psychotic-depressive disorders: Measurement of antidepressant metabolites. South Med J 76: 991–5.

J. R. Calabrese , P. B. Keck , W. MacFadden , et al. 2005. A randomized double-blind placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 162: 1351–60.

W. T. Carpenter and R. W. Buchanan 1994. Schizophrenia. N Engl J Med 330: 681–90.

B. J. Carroll 1982. The dexamethasone suppression test for melancholia. Br J Psychiatry 140: 292–304.

B. J. Carroll , G. C. Curtis , and J. Mendels 1976. Cerebrospinal fluid and plasma free cortisol concentrations in depression. Psychol Med 6: 235–44.

I. Chelminski , M. Zimmerman , and J. I. Mattia 2000. Diagnosing melancholia. J Clin Psychiatry 61: 874–5.

Chouinard, G. and Steinberg, S. 1984. New clinical concepts on neuroleptic-induced supersensitivity disorders: Tardive dyskinesia and supersensitivity psychosis. In H. C. Stancer , P. E. Garfinkel , and V. M. Rakoff (eds) Guidelines for the use of psychotropic drugs. New York: Spectrum, pp. 205–27.

W. Coryell and M. T. Tsuang 1982. Primary unipolar depression and the prognostic importance of delusions. Arch Gen Psychiatry 39: 1181–4.

W. Coryell , B. Pfohl , and M. Zimmerman 1984. The clinical and neuroendocrine features of pscyhotic depression. J Nerv Ment Dis 172: 521–8.

W. Coryell , M. Zimmerman , and B. Pfohl 1986. Outcome at discharge and six months in major depression. The significance of psychotic features. J Nerv Ment Dis 174: 92–6

J. Davidson , M. McLeod , B. Law-Yone , and M. Linnoila 1978. A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression. Arch Gen Psychiatry 35: 639–42.

C. DeBattista , J. Belanoff , S. Glass , et al. 2006. Mifeprisone versus placebo in the treatment of psychosis in patients with psychotic major depression. Biol Psychiatry 60: 1343–9.

C. Montigny , F. Grunberg , A. Mayer , et al. 1981. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry 138: 252–6.

M. P. DelBello , G. A. Carlson , M. Tohen , et al. 2003. Rates and predictors of developing a manic or hypomanic episode 1 to 2 years following a first hospitalization for major depression with psychotic features. J Child Adolesc Psychopharmacol 13: 173–85.

J. M. Eagles 1983. Delusional depressive in-patients, 1892–1982. Br J Psychiatry 143: 558–63.

A. Erfurth , J. Walden , and H. Grunze 1998. Lamotrigine in the treatment of schizoaffective disorder. Neuropsychobiology 38: 204–5.

D. L. Evans and C. B. Nemeroff 1987. The clinical use of the Dexamethasone Suppression Test in DSM-III affective disorders: Correlation with the severe depressive subtypes of melancholia and psychosis. J Psychiatr Res 21: 185–94.

J. P. Feighner , E. Robins , S. B. Guze , et al. 1972. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26: 57–63.

M. Fink and M. A. Taylor 2003. Catatonia: A clinician's guide to diagnosis and treatment. New York: Cambridge University Press.

M. Fink , D. F. Klein , and J. C. Kramer 1965. Clinical efficacy of chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders. Psychopharmacologia 7: 27–36.

R. Finlay-Jones and G. Parker 1993. A consensus conference on psychotic depression. Aust NZ J Psychiatry 27: 581–9.

A. J. Flint and S. L. Rifat 1998a. The treatment of psychotic depression in later life: A comparison of pharmacotherapy and ECT. Int J Geriatr Psychiatry 13: 23–8.

G. L. Fricchione , N. H. Cassem , and D. Hooberman 1983. Intravenous lorazepam in neuroleptic-induced catatonia. J Clin Psychopharmacol 3: 338–42.

B. C. Frueh , R. G. Knapp , K. J. Cusack , et al. 2005. Patients' reports of traumatic or harmful experience within the psychiatric setting. Psychiatric Serv 56: 1123–33.

R. Gaupp 1926. Krankheitseinheit und mischpsychosen. Zeitschrift fur die gesamte Neurologie und Psychiatrie 101: 1–15.

S. N. Ghaemi , M. S. Lenox , and R. J. Baldessarini 2001. Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J Clin Psychiatry 62: 565–9.

U. Gimsa , U. Schreiber , B. Habel , et al. 2006. Matching geometry and stimulation parameters of electrodes for deep brain stimulation experiments – numerical considerations. J Neurosci Meth 150: 212–27.

A. H. Glassman and S. P. Roose 1981. Delusional depression: A distinct clinical entity? Arch Gen Psychiatry 38: 424–7.

I. D. Glick , S. R. Murray , P. Vasudevan , et al. 2001. Treatment with atypical antipsychotics: New indications and new populations. J Psychiatr Res 35: 187–91.

J. L. Goren and G. M. Levin 2000. Mania with bupropion: A dose-related phenomenon? Ann Pharmacother 34: 619–21.

R. Gournellis , L. Lykouras , A. Fortos , et al. 2001. Psychotic (delusional) major depression in late life: A clinical study. Int J Geriatr Psychiatry 16: 1085–91.

L. Grunhaus , P. N. Dannon , S. Schreiber , et al. 2000. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: An open study. Biol Psychiatry 47: 314–24.

H. Grunze , A. Marcuse , L. O. Scharer , et al. 2002. Nefazodone in psychotic unipolar and bipolar depression: A retrospective chart analysis and open prospective study on its efficacy and safety versus combined treatment with amitriptyline and haloperidol. Neuropsychobiology 46(Suppl 1): 31–5.

S. B. Guze , R. A. Woodruff , Jr, and P. J. Clayton 1975. The significance of psychotic affective disorders. Arch Gen Psychiatry 32: 1147–50.

M. Hamilton 1989. Frequency of symptoms in melancholia (depressive illness). Br J Psychiatry 154: 201–6.

S. K. Hill , M. S. Keshavan , M. E. Thase , and J. A. Sweeney 2004. Neuropsychological dysfunction in antipsychotic-naïve first-episode unipolar psychotic depression. Am J Psychiatry 161: 996–1003.

A. Hoch and J. T. MacCurdy 1922 The prognosis of involution melancholia. Arch Neurol Psychiatry 7: 1–37.

L. E. Hollister and J. E. Overall 1965. Reflections on the specificity of action of anti-depressants. Psychosomatics 6: 361–5.

P. Honoré , S. E. Moller , and A. Jorgensen 1982. Lithium + l-tryptophan compared with amitriptyline in endogenous depression. J Affect Disord 4: 79–82.

M. Jager , R. Bottlender , A. Strauss , and H. J. Moller 2005. Fifteen-year follow-up of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition depressive disorders: The prognostic significance of psychotic features. Compr Psychiatry 46: 322–7.

V. Jain and C. M. Swartz 2002. Charcoal enhancement of treatment for tricyclic-induced mania. Pharmacopsychiatry 35: 197–9.

R. T. Joffe , G. M. MacQueen , M. Marriott , et al. 2002. Induction of mania and cycle acceleration in bipolar disorder: Effect of different classes of antidepressant. Acta Psychiatr Scand 105: 427–30.

J. Johnson , E. Horwath , and M. M. Weissman 1991. The validity of major depression with psychotic features based on a community study. Arch Gen Psychiatry 48: 1075–81.

K. S. Joseph , L. Blais , P. Ernst , and S. Suissa 1996. Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers. BMJ 312(7023): 79–82.

L. L. Judd , H. S. Akiskal , P. J. Schettler , et al. 2002. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 59: 530–7.

L. L. Judd , M. J. Paulus , P. J. Schettler , et al. 2000. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 157: 1501–4.

S. J. Kantor and A. H. Glassman 1977. Delusional depressions: Natural history and response to treatment. Br J Psychiatry 131: 351–60.

C. H. Kellner , M. Fink , R. Knapp , et al. 2005. Relief of expressed suicidal intent by ECT: A consortium for research in ECT study. Am J Psychiatry 162: 977–82.

R. E. Kendell , J. C. Chalmers , and C. Platz 1987. Epidemiology of puerperal psychoses. Br J Psychiatry 150: 662–73.

L. G. Kiloh and R. F. Garside 1963. The independence of neurotic depression and endogenous depression. Br J Psychiatry 109: 451–63.

L. G. Kiloh and R. F. Garside 1977. Depression: A multivariate study of Sir Aubrey Lewis's data on melancholia. Aust NZ J Psychiatry 11: 149–56.

V. Kinross-Wright 1955. Chlorpromazine treatment of mental disorders. Am J Psychiatry 111: 907–12.

S. Kiser 2004. An existential case study of madness: Encounters with divine affliction. J Human Psychol 44: 431–54.

D. Klein and M. Fink 1962. Behavioral reaction patterns with phenothiazines. Arch Gen Psychiatry 7: 449–59.

H. Kuhs 1991. Depressive delusion. Psychopathology 24: 106– 14.

La A. Rue , J. Spar , and C. D. Hill 1986. Cognitive impairment in late-life depression: Clinical correlates and treatment implications. J Affect Disord 11: 179–84

M. V. Lambert and M. M. Robertson 1999. Depression in epilepsy: Etiology, phenomenology, and treatment. Epilepsia 40(Suppl 10): S21–S47.

P. E. Lee , K. Sykora , S. S. Gill , et al. 2005. Antipsychotic medications and drug-induced movement disorders other than parkinsonism: A population-based cohort study in older adults. J Am Geriatr Soc 53: 1374–9.

I. M. Lesser , R. T. Rubin , A. Rifkin , et al. 1989. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment. J Affect Disord 16: 49–58.

A. Lewis 1971. “Endogenous” and “exogenous”: A useful dichotomy? Psychol Med 1: 191–6.

D. A. Lewis and R. E. Smith 1983. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord 5: 319–32.

M. L. Lu , J. J. Pan , H. W. Teng , et al. 2002. Metoclopramide-induced supersensitivity psychosis. Ann Pharmacother 36: 1387–90.

E. Lykouras , D. Malliaras , G. N. Christodoulou , et al. 1986a. Delusional depression: Phenomenology and response to treatment. Psychopathology 19: 157–64.

E. Lykouras , D. Malliaras , G. N. Christodoulou , et al. 1986b. Delusional depression: Phenomenology and response to treatment. A prospective study. Acta Psychiatr Scand 73: 324–9.

M. Maj , R. Pirozzi , and Di E. L. Caprio 1990. Major depression with mood-congruent psychotic features: A distinct diagnostic entity or a more severe subtype of depression? Acta Psychiatr Scand 82: 439–44.

A. K. Malla , R. M. Norman , R. Manchanda , et al. 2002. One year outcome in first episode psychosis: Influence of DUP and other predictors. Schizophr Res 54: 231–42.

H. C. Margolese , G. Chouinard , L. Beauclair , and M. C. Belanger 2002. Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder. J Clin Psychopharmacol 22: 347–52.

L. Marsh , J. R. Williams , M. Rocco , et al. 2004. Psychiatric comorbidities associated with psychosis in patients with Parkinson's disease. Neurology 63: 293–300.

M. Marshall , S. Lewis , A. Lockwood , et al. 2005. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients. Arch Gen Psychiatry 62: 975–83.

B. J. Mason , J. H. Kocsis , A. J. Frances , and J. J. Mann 1990. Amoxapine versus amitriptyline for continuation therapy of depression. J Clin Psychopharmacol 10: 338–43.

K. M. Masters and D. Wandless 2005. Use of pulse oximetry during restraint episodes. Psychiatr Serv 56: 1313–14.

H. Maudsley 1867. The physiology and pathology of mind. New York: Appleton.

H. S. Mayberg , A. M. Lozano , V. Voon , et al. 2005. Deep brain stimulation for treatment-resistant depression. Neuron 45: 651–60.

R. McIntyre , D. A. Mancini , S. McCann , et al. 2002. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: A preliminary single-blind study. Bipolar Disord 4: 207–13.

J. H. Meyer , S. Kruger , A. A. Wilson , et al. 2001. Lower dopamine transporter binding potential in striatum during depression. Neuroreport 12: 4121–5.

B. S. Meyers , S. A. Klimstra , M. Gabriele , et al. 2001. Continuation treatment of delusional depression in older adults. Am J Geriatr Psychiatry 9: 415–22.

N. R. Mirza , J. L. Bright , K. J. Stanhope , et al. 2005. Lamotrigine has an anxiolytic-like profile in the rat conditioned emotional response test of anxiety: A potential role for sodium channels? Psychopharmacol (Berlin) 180: 159–68.

K. T. Mueser , L. B. Goodman , S. L. Trumbetta , et al. 1998. Trauma and posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol 66: 493–9.

F. Muller-Siecheneder , M. J. Muller , A. Hillert , et al. 1998. Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome. J Clin Psychopharmacol 18: 111–20.

B. H. Mulsant , R. A. Sweet , J. Rosen , et al. 2001. A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life. J Clin Psychiatry 62: 597–604.

B. S. Myers and R. Greenberg 1986. Late-life delusional depression. J Affect Disord 11: 133–7.

P. S. Naidu and S. K. Kulkarni 2001. Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): Possible involvement of calcium and nitric oxide. Behav Pharmacol 12: 209–16.

D. Naimark , E. Jackson , E. Rockwell , and D. V. Jeste 1996. Psychotic symptoms in Parkinson's disease patients with dementia. J Am Geriatr Soc 44: 296–9.

V. Navarro , C. Gasto , X. Torres , et al. 2001. Citalopram versus nortriptyline in late-life depression: A 12-week randomized single-blind study. Acta Psychiatr Scand 103: 435–40.

J. C. Nelson and M. B. Bowers Jr.1978. Delusional unipolar depression: Description and drug response. Arch Gen Psychiatry 35: 1321–8.

J. C. Nelson , D. S. Charney , and D. M. Quinlan 1981. Evaluation of the DSM-III criteria for melancholia. Arch Gen Psychiatry 38: 555–9.

L. A. Nelson and C. M. Swartz 2000. Melancholic symptoms from concurrent olanzapine and fluoxetine. Ann Clin Psychiatry 12: 167–70.

M. Olfson , S. Marcus , H. A. Sackeim , J. Thompson , and H. A. Pincus 1998. Use of ECT for the inpatient treatment of recurrent major depression. Am J Psychiatry 155: 2–29.

J. E. Overall , L. E. Hollister , M. Johnson , and V. Pennington 1966. Nosology of depression and differential response to drugs. JAMA 195: 946–8.

J. E. Overall , L. E. Hollister , A. D. Pokorny , et al. 1962. Drug therapy in depressions: Controlled evaluation of imipramine, isocarboxazide, dextroamphetamine-amobarbital, and placebo. Clin Pharmacol Ther 3: 16–22.

M. Pai , A. C. White , and A. G. Deane 1986. Lithium augmentation in the treatment of delusional depression. Br J Psychiatry 148: 736–8.

G. I. Papakostas , J. E. Alpert , and M. Fava 2003. S-adenosyl-methionine in depression: A comprehensive review of the literature. Curr Psychiatry Rep 5: 460–6.

G. Parker 2000. Classifying depression: Should paradigms lost be regained? Am J Psychiatry 157: 1195–203.

G. Parker 2004. Evaluating treatments for the mood disorders: Time for the evidence to get real. Aust NZ J Psychiatry 38: 408–14.

G. Parker , D. Hadzi-Pavlovic , H. Brodaty , et al. 1995. Sub-typing depression, II. Clinical distinction of psychotic depression and non-psychotic melancholia. Psychol Med 25: 825–32.

G. Parker , D. Hadzi-Pavlovic , I. Hickie , et al. 1991a. Distinguishing psychotic and non-psychotic melancholia. J Affect Disord 22: 135–48.

G. Parker , D. Hadzi-Pavlovic , I. Hickie , et al. 1991b. Psychotic depression: A review and clinical experience. Aust NZ J Psychiatry 25: 169–80.

G. Parker , J. Roussos , P. Mitchell , et al. 1997. Distinguishing psychotic depression from melancholia. J Affect Disord 42: 155–67.

G. Parker , K. Roy , D. Hadzi-Pavlovic , and F. Pedic 1992. Psychotic (delusional) depression: A meta-analysis of physical treatments. J Affect Disord 24: 17–24.

M. M. Parvin , C. M. Swartz , and B. LaMontagne 2004. Patient education by ECT experienced volunteer. J ECT 20: 127–9.

P. J. Perry , D. E. Morgan , R. E. Smith , and M. T. Tsuang 1982. Treatment of unipolar depression accompanied by delusions. ECT versus tricyclic antidepressant – antipsychotic combinations. J Affect Disord 4: 195–200.

G. Petrides , M. Fink , M. M. Husain , et al. 2001. ECT remission rates in psychotic versus nonpsychotic depressed patients: A report from CORE. J ECT 17: 244–53.

S. D. Piasecki and J. W. Jefferson 2004. Psychiatric complications of deep brain stimulation for Parkinson's disease. J Clin Psychiatry 65: 845–9.

P. Pollak , F. Tison , O. Rascol , et al. 2004. Clozapine in drug induced psychosis in Parkinson's disease: A randomised, placebo controlled study with open follow up. J Neurol Neurosurg Psychiatry 75: 689–95.

H. G. Pope and D. L. Katz 1994. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch Gen Psychiatry 51: 375–82.

A. P. Popli , M. A. Fuller , and G. E. Jaskiw 1997. Sertraline and psychotic symptoms: A case series. Ann Clin Psychiatry 9: 15–17.

J. P. Price 1978. Chronic depressive illness. BMJ 1: 1200–1.

R. F. Prien , D. J. Kupfer , P. A. Mansky , et al. 1984. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 41: 1096–104.

E. A. Rabiner , Z. Bhagwagar , R. N. Gunn , et al. 2001. Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low. Am J Psychiatry 158: 2080–2.

M. Raja and A. Azzoni 2003. Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders. Int J Neuropsychopharmacol 6: 409–14.

R. Ranjan and H. Y. Meltzer 1996. Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression. Biol Psychiatry 40: 253–8.

M. H. Rapaport , L. L. Judd , P. J. Schettler , et al. 2002. A descriptive analysis of minor depression. Am J Psychiatry 159: 637–43.

R. Ries and J. Bokan 1979. Electroconvulsive therapy following pituitary surgery. J Nerv Ment Dis 167: 767–8.

A. D. T. Robinson 1988. A century of delusions in south west Scotland. Br J Psychiatry 153: 163–7.

S. P. Roose , H. A. Sackeim , K. R. Krisnan R., et al. 2004. Antidepressant pharmacotherapy in the treatment of depression in the very old: A randomized, placebo-controlled trial. Am J Psychiatry 161: 2050–9.

S. A. Ropacki and D. V. Jeste 2005. Epidemiology of and risk factors for psychosis of Alzheimer's disease: A review of 55 studies published from 1990 to 2003. Am J Psychiatry 162: 2022–30.

A. J. Rothschild and S. E. Duval 2003. How long should patients with psychotic depression stay on the antipsychotic medication? J Clin Psychiatry 64: 390–6.

A. J. Rothschild and K. A. Phillips 1999. Selective serotonin inhibitors and delusional depression. Am J Psychiatry 156: 977–8.

A. J. Rothschild , D. J. Williamson , M. F. Tohen , et al. 2004. A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. J Clin Psychopharmacol 24: 365–73.

A. J. Rush , L. B. Marangell , H. A. Sackeim , et al. 2005. Vagus nerve stimulation for treatment-resistant depression: A randomized, controlled acute phase trial. Biol Psychiatry 58: 347–54.

H. A. Sackeim , J. Prudic , D. P. Devanand , et al. 1993. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 328: 839–46.

J. R. Sanchez-Ramos , R. Ortoll , and G. W. Paulson 1996. Visual hallucinations associated with Parkinson disease. Arch Neurol 53: 1265–8.

J. Sareen , B. J. Cox , T. O. Afifi , et al. 2005. Anxiety disorders and risk for suicidal ideation and suicide attempts. Arch Gen Psychiatry 62: 1249–57.

A. F. Schatzberg , J. A. Posener , C. DeBattista , et al. 2000. Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness. Am J Psychiatry 157: 1095–100.

J. J. Schildkraut 1965. The catecholamine hypothesis of affective disorders: A review of supporting evidence. Am J Psychiatry 122: 509–22.

M. Schmauss , H. P. Kapfhammer , P. Meyr , and P. Hoff 1988. Combined MAO-inhibitor and tri- (tetra) cyclic antidepressant treatment in therapy resistant depression. Prog Neuropsychopharmacol Biol Psychiatry 12: 523–32.

K. Schneider 1920. Die schichtung des emotionalen lebens und der aufbau der depressionszustände. Zeitschrift für die gesamte Neurologie und Psychiatrie 59: 281–6.

L. S. Schneider , K. S. Dagerman , and P. Insel 2005. Risk of death with atypical antipsychotic drug treatment for dementia. JAMA 294: 1934–43.

L. S. Schneider , J. C. Nelson , C. M. Clary , et al. 2003. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry 160: 1277–85.

A. C. Schwartz , R. L. Bradley , M. Sexton , et al. 2005. Posttraumatic stress disorder among African Americans in an inner city mental health clinic. Psychiatr Serv 56: 212–15.

E. Shorter 1990. Private clinics in central Europe 1850–1933. Soc Hist Med 3: 159–95.

G. M. Simpson , A. El Sheshai , A. Rady , et al. 2003. Sertraline as monotherapy in the treatment of psychotic and nonpsychotic depression. J Clin Psychiatry 64: 959–65.

S. Simpson , R. C. Baldwin , A. Jackson , and A. Burns 1999. The differentiation of DSM-III-R psychotic depression in later life from nonpsychotic depression: Comparisons of brain changes measured by multispectral analysis of magnetic resonance brain images, neuropsychological findings, and clinical features. Biol Psychiatry 45: 193–204.

R. L. Spitzer , J. Endicott , and E. Robins 1978. Research diagnostic criteria: Rationale and reliability. Arch Gen Psychiatry 35: 773–82.

S. E. Starkstein , R. Jorge , R. Mizrahi , and R. G. Robinson 2005. The construct of minor and major depression in Alzheimer's Disease. Am J Psychiatry 162: 2086–93.

J. H. Stephens and P. R. McHugh 1991. Characteristics and long-term follow-up of patients hospitalized for mood disorders in the Phipps Clinic, 1913–1940. J Nerv Ment Dis 179: 64–73.

C. Stevinson and E. Ernst 2004. Can St. John's wort trigger psychosis? Int J Clin Pharmacol Ther 42: 473–80.

S. M. Strakowski , M. Flaum , X. Amador , et al. 1996. Racial differences in the diagnosis of psychosis. Schizophrenia Res 21: 117–24.

D. Stueber and C. M. Swartz 2006. Carvedilol suppresses intractable hiccups. J Am Board Fam Med 19: 418–21.

C. M. Swartz 1979. Depression with nonauditory hallucinations: Success with phenelzine. Psychosomatics 20: 286–7.

C. M. Swartz 1982. Dependency of antidepressant efficacy on thyroid hormone potentiation: Case studies. J Nerv Ment Dis 170: 50–2.

C. M. Swartz 1984. The justification for ECT. Behav Brain Sci 7: 37.

C. M. Swartz 1995. Tardive psychopathology. Neuropsychobiology 32: 115–19.

C. M. Swartz 2000. Physiological response to ECT stimulus dose. Psychiatry Res 97: 229–35.

C. M. Swartz 2001a. Misdiagnosis of schizophrenia for a patient with epilepsy. Psychiatr Serv 52: 109.

C. M. Swartz 2001b Olanzapine-lithium encephalopathy. Psychosomatics 42: 370.

C. M. Swartz 2002. Olanzapine-induced depression. J Pharm Technol 18: 321–3.

C. M. Swartz 2005. Aspiration and postictal agitation after electroconvulsive therapy with propofol but no succinylcholine or atropinic agent. J ECT 21: 50–1.

C. M. Swartz and R. L. Galang 2001. Adverse outcome with delay in catatonia identification in elderly patients. Am J Geriatric Psychiatry 9: 78–80.

C. M. Swartz and G. Guadagno 1998. Melancholia with onset during treatment with SSRIs. Ann Clin Psychiatry 10: 177–9.

C. M. Swartz and D. T. Manly 2000. Efficiency of the stimulus characteristics of ECT. Am J Psychiatry 157: 1504–6.

C. M. Swartz , V. Morrow , L. Surles , and J. F. James 2001. Long-term outcome after ECT for catatonic depression. J ECT 17: 180–3.

M. A. Taylor and M. Fink 2006. Melancholia: The diagnosis, pathophysiology, and treatment of depressive illness. Cambridge, UK: Cambridge University Press.

M. T. Tsuang , M. Dempsey , and F. Rauscher 1976. A study of atypical schizophrenia. Arch Gen Psychiatry 33: 1157–60.

M. T. Tsuang , R. F. Woolson , and J. A. Fleming 1979. Long-term outcome of major psychoses. Arch Gen Psychiatry 36: 1295–304.

N. W. Broek , T. K. Birkenhager , P. G. Mulder , et al. 2006. Imipramine is effective in preventing relapse in electro convulsive therapy-responsive depressed inpatients with prior pharmacotheraphy treatment failure: a randomized, placebo-controlled trial. J Clin Psychiatry 67: 263–8.

A. C. Viguera , R. J. Baldessarini , J. D. Hegarty , et al. 1997. Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Arch Gen Psychiatry 54: 49–55.

M. Vythilingam , J. Chen , J. D. Bremner , et al. 2003. Psychotic depression and mortality. Am J Psychiatry 160: 574–6.

H. Wada , K. Nakajoh , T. Satoh-Nakagawa , et al. 2001. Risk factors of aspiration pneumonia in Alzheimer's disease patients. Gerontology 47: 271–6.

S. Walen 2002. It's a funny thing about suicide: A personal experience. Br J Guid Couns 30: 415–30.

E. Weiss , M. Hummer , D. Koller , et al. 2000. Off-label use of antipsychotic drugs. J Clin Psychopharmacol 20: 695–8.

D. Wheatley 1972. Potentiation of amitriptyline by thyroid hormone. Arch Gen Psychiatry 26: 229–33.

P. Whitty , M. Clarke , O. McTigue , et al. 2005. Diagnostic stability four years after a first episode of psychosis. Psychiatr Serv 56: 1084–8.

J. A. Wilcox , A. L. Ramirez , and N. Baida-Fragoso 2000. The prognostic value of thought disorder in psychotic depression. Ann Clin Psychiatry 12: 1–4.

O. M. Wolkowitz , V. I. Reus , T. Chan , et al. 1999. Antiglucocorticoid treatment of depression: Double-blind ketoconazole. Biol Psychiatry 45: 1070–4.

R. Zanardi , L. Franchini , M. Gasperini , et al. 1997. Long-term treatment of psychotic (delusional) depression with fluvoxamine: An open pilot study. Int Clin Psychopharmacol 12: 195–7.

R. Zanardi , L. Franchini , M. Gasperini , et al. 1998. Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: A controlled study. J Clin Psychopharmacol 18: 441–6.

R. Zanardi , L. Franchini , J. Perez , et al. 1999. Dr. Zanardi and colleagues reply. Am J Psychiatry 156: 978.

R. Zanardi , L. Franchini , A. Serretti , et al. 2000. Venlafaxine versus fluvoxamine in the treatment of delusional depression: A pilot double-blind controlled study. J Clin Psychiatry 61: 26–9.

M. Zimmerman , I. Chelminski , and W. McDermut 2002. Major depressive disorder and axis I diagnostic comorbidity. J Clin Psychiatry 63: 187–93.

P. Zwanzger , R. Ella , M. E. Keck , R. Rupprecht , and F. Padberg 2002. Occurrence of delusions during repetitive transcranial magnetic stimulation (rTMS) in major depression. Biol Psychiatry 51: 602–3.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 25 *
Loading metrics...

Book summary page views

Total views: 183 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 21st July 2017. This data will be updated every 24 hours.